THORN RUN PARTNERS

Lobbying for ARDELYX, INC. · Pharmaceutical manufacturer

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income · posted Jul 15, 2025

Lobbying activity 1

Health Issues

Issues related to Medicare ESRD benefit and chronic kidney disease management.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem